261 related articles for article (PubMed ID: 33570013)
21. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
Zhang P; Xu P; Chung S; Bandari S; Repka MA
Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
[TBL] [Abstract][Full Text] [Related]
22. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
23. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
24. Predicting drug release from diazepam FDM printed tablets using deep learning approach: Influence of process parameters and tablet surface/volume ratio.
Obeid S; Madžarević M; Krkobabić M; Ibrić S
Int J Pharm; 2021 May; 601():120507. PubMed ID: 33766640
[TBL] [Abstract][Full Text] [Related]
25. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
26. An investigation into the effects of geometric scaling and pore structure on drug dose and release of 3D printed solid dosage forms.
McDonagh T; Belton P; Qi S
Eur J Pharm Biopharm; 2022 Aug; 177():113-125. PubMed ID: 35779743
[TBL] [Abstract][Full Text] [Related]
27. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
[TBL] [Abstract][Full Text] [Related]
28. [Preparation and
Li ZS; Qian HN; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):572-577. PubMed ID: 35701138
[TBL] [Abstract][Full Text] [Related]
29. Multiple variable effects in the customisation of fused deposition modelling 3D-printed medicines: A design of experiments (DoE) approach.
Dos Santos J; Deon M; da Silva GS; Beck RCR
Int J Pharm; 2021 Mar; 597():120331. PubMed ID: 33540012
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
[TBL] [Abstract][Full Text] [Related]
31. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C
Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471
[TBL] [Abstract][Full Text] [Related]
32. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.
Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW
Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653
[TBL] [Abstract][Full Text] [Related]
33. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms.
Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR
Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280
[TBL] [Abstract][Full Text] [Related]
34. Speed it up, slow it down…An issue of bicalutamide release from 3D printed tablets.
Jamróz W; Kurek M; Szafraniec-Szczęsny J; Czech A; Gawlak K; Knapik-Kowalczuk J; Leszczyński B; Wróbel A; Paluch M; Jachowicz R
Eur J Pharm Sci; 2020 Feb; 143():105169. PubMed ID: 31785383
[TBL] [Abstract][Full Text] [Related]
35. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing.
Skowyra J; Pietrzak K; Alhnan MA
Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545
[TBL] [Abstract][Full Text] [Related]
36. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
[TBL] [Abstract][Full Text] [Related]
37. 3D printing: An appealing route for customized drug delivery systems.
Elkasabgy NA; Mahmoud AA; Maged A
Int J Pharm; 2020 Oct; 588():119732. PubMed ID: 32768528
[TBL] [Abstract][Full Text] [Related]
38. The evaluation of the effect of different superdisintegrants on the drug release from FDM 3D printed tablets through different applied strategies: In vitro-in silico assessment.
Đuranović M; Madžarević M; Ivković B; Ibrić S; Cvijić S
Int J Pharm; 2021 Dec; 610():121194. PubMed ID: 34728321
[TBL] [Abstract][Full Text] [Related]
39. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
[TBL] [Abstract][Full Text] [Related]
40. An Intragastric Delivery Device Employing FDM Technology: 3D-Printed Tablet Containing Green Developed Mosapride-Saccharin Co-crystals.
Amin OM; El Qady HN; Abd El-Fattah MA
AAPS PharmSciTech; 2023 Jun; 24(5):127. PubMed ID: 37264247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
